Knight Therapeutics (KHTRF) Rating Reiterated by Raymond James  Fairfield Current

Knight Therapeutics (OTCMKTS:KHTRF)’s stock had its “buy” rating reaffirmed by equities researchers at Raymond James in a note issued to investors on …